Phenotype determination of anti-GM3 positive cells in atherosclerotic lesions of the human aorta. Hypothetical role of ganglioside GM3 in foam cell formation.
Earlier we reported that atherosclerotic plaques contain cells which were specifically and very intensively stained with anti-GM3 antibodies although no GM3 positive cells were detected in the normal non-diseased arterial intima. Because of their lipid inclusions, GM3 positive cells in atherosclerotic lesions seemed to be foam cells but their origin needed clarification. Using an immunohistochemical technique in the present work, we showed that some of these foam cells contained CD68 antigen. However, the most intense accumulation of GM3 occurred in the areas composed of foam cells which did not stain with any cell type-specific antibodies, including antibodies to macrophages (anti-CD68) and smooth muscle cells (anti-smooth muscle alpha-actin), perhaps, because the cell type-specific antigens were lost during the transformation of intimal cells into foam cells. Ultrastructural analysis of the areas where foam cells overexpressed GM3 demonstrated that some foam cells lacked both a basal membrane and myofilaments but contained a large number of secondary lysosomes and phagolysosomes, morphological features which might indicate their macrophage origin. Other foam cells contained a few myofilaments and fragments of basal membrane around their plasmalemmal membrane, suggesting a smooth muscle cell origin. These observations indicate that accumulation of excessive amounts of GM3 occurs in different cell types transforming into foam cells. We suggest that up-regulation of GM3 synthesis in intimal cells might be an essential event in foam cell formation. Shedding of a large number of membrane-bound microvesicles from the cell surface of foam cells was observed in areas of atherosclerotic lesions corresponding to extracellular GM3 accumulation. We speculate that extracellularly localised GM3 might affect the differentiation and modification of intimal cells in atherosclerotic lesions.
Bobryshev
Y V
YV
Surgical Professional Unit, St. Vincent's Hospital, University of New South Wales, Sydney, Australia.
Lord
R S
RS
Golovanova
N K
NK
Gracheva
E V
EV
Zvezdina
N D
ND
Prokazova
N V
NV
D000328:Adult; D000906:Antibodies / Q000032:analysis; D015703:Antigens, CD / Q000032:analysis; D001018:Aortic Diseases / Q000378:metabolism* / Q000473:pathology; D001161:Arteriosclerosis / Q000378:metabolism* / Q000473:pathology; D000071178:CD48 Antigen; D005487:Foam Cells / Q000378:metabolism* / Q000473:pathology / Q000648:ultrastructure; D005679:G(M3) Ganglioside / Q000032:analysis / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D008077:Lipoproteins, LDL / Q000032:analysis / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009131:Muscle, Smooth, Vascular / Q000378:metabolism / Q000473:pathology / Q000648:ultrastructure; D010641:Phenotype; D017539:Tunica Intima / Q000378:metabolism / Q000473:pathology
D000906:Antibodies; D015703:Antigens, CD; D000071178:CD48 Antigen; D005679:G(M3) Ganglioside; D008077:Lipoproteins, LDL; C099252:oxidized low density lipoprotein